Detection and Quant of Differences in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma Using Positron Emission Tomography/Computed Tomography (PET/CT)

Completed · Not applicable

Conditions studied: Lymphoma

In brief

RATIONALE: Imaging procedures, such as positron emission tomography or computed tomography, may help in detecting differences between Hodgkin lymphoma or diffuse large B-cell lymphoma cancer cells. PURPOSE: This clinical trial is studying positron emission tomogaphy and computed tomography in determining differences in Hodgkin lymphoma and diffuse large B-cell lymphoma.

Key facts

Study ID

NCT01004718

Run by

Abramson Cancer Center at Penn Medicine

People needed

10

Starts

2009-05-01

Expected to finish

2014-11-05

Last updated by the study team

2021-05-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects with a pathologically-proven diagnosis of classic HL or DLBCL with measurable disease by any imaging technique or physical examination.

You may not qualify if…

• Pregnant or nursing,
• Uncontrolled diabetes mellitus,
• Active infection,
• Inability to give informed consent or to comply with all study procedures,
• Subjects may be excluded at the discretion of the principal investigator or study team members.

Where it is running

• Abramson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.